Where does Nicola Aceto work?

Nicola Aceto is Co-founder, Chief Science Officer of Page Therapeutics.

What companies did Nicola Aceto found?

Nicola Aceto founded Page Therapeutics.

Where did Nicola Aceto go to school?

Nicola Aceto studied at Broad Institute of MIT and Harvard, Boston, MA, USA (Cancer Computational Biology Program); Friedrich Miescher Institute for Biomedical Research, University of Basel, Switzerland (Doctor of Philosophy (Ph.D.), Oncology and Cancer Biology); Università degli Studi del Piemonte Orientale (Master's Degree, Medical and Pharmaceutical Biotechnology).

Nicola Aceto

Founder

Co-founder, Chief Science Officer at Page Therapeutics

Zurich, Zurich, Switzerland

FoundedPage Therapeutics

Find your path to Nicola

187 people in our graph can introduce you to Nicola.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Fabrice Kolb to introduce you to Nicola

You →Fabrice · together at Friedrich Miescher Institute for Biomedical Research (2006) →Nicola

Ask Jamie Chen to introduce you to Nicola

You →Jamie · together at Friedrich Miescher Institute for Biomedical Research →Nicola

Ask Sam Okafor to introduce you to Nicola

You →Sam · 5 people · together at Page Therapeutics →Nicola

Your email: the people you already email who know Nicola
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Nicola
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Co-founder, Chief Science Officer at Page Therapeutics

Intro paths

→

In turn, Nicola can intro founders to Page Therapeutics's investors below.

Page Therapeutics's investors · 2

Claris VenturesTorino XGEN VentureMilan

Co-founders at Page Therapeutics

Christoph RochlitzCo-founder & Chief Medical Officer

Prof. Dr. Med. Christoph RochlitzCo-founder, Chief Medical Officer

Experience

ETH ZürichFull Professor of Molecular Oncologycurrent2024 — presentZurich, Switzerland
ETH ZürichAssociate (Tenured) Professor of Molecular Oncology2021 — 2024Zurich, Switzerland
PAGE Therapeutics AGScientific Founder and Executive Board Membercurrent2022 — presentSwitzerland
University of BaselGroup Leader and Assistant Professor of Oncology, University of Basel2015 — 2021Basel Area, Switzerland
Broad Institute of MIT and HarvardAssociate Member, Broad Institute of MIT and Harvard2014 — 2015Greater Boston Area
Harvard Medical School and Massachusetts General HospitalResearch Fellow, MGH Cancer Center, Harvard Medical School2012 — 2015Greater Boston Area
Friedrich Miescher Institute for Biomedical ResearchPostdoctoral Fellow2011 — 2012Basel Area, Switzerland
Friedrich Miescher Institute for Biomedical ResearchPh.D. Student2006 — 2011Basel Area, Switzerland

Skills & more

ScienceCancerMolecular BiologyCellCell BiologyBiochemistryWestern BlottingCell CultureLife SciencesFluorescence Microscopy

Languages English · Italian

From Nicola's professional profile.

Frequently asked questions

Who is Nicola Aceto?: Co-founder & Chief Science Officer at Page Therapeutics
Where does Nicola Aceto work?: Nicola Aceto is Co-founder, Chief Science Officer of Page Therapeutics.
What companies did Nicola Aceto found?: Nicola Aceto founded Page Therapeutics.
Where did Nicola Aceto go to school?: Nicola Aceto studied at Broad Institute of MIT and Harvard, Boston, MA, USA (Cancer Computational Biology Program); Friedrich Miescher Institute for Biomedical Research, University of Basel, Switzerland (Doctor of Philosophy (Ph.D.), Oncology and Cancer Biology); Università degli Studi del Piemonte Orientale (Master's Degree, Medical and Pharmaceutical Biotechnology).